734 results on '"Michalski, Christoph W"'
Search Results
202. The evidence based dilemma of intraperitoneal drainage for pancreatic resection – a systematic review and meta-analysis
203. Epigenetic changes mediated by the polycomb repressor complex 1 in acinar-to-ductal metaplasia and pancreatic carcinogenesis.
204. The role of the type I interferon receptor in regeneration of a cerulein- induced pancreatitis
205. Multimodal Molecular Imaging of Integrin αvβ3 for In Vivo Detection of Pancreatic Cancer
206. Mucinous and Signet-Ring Cell Colorectal Cancers Differ from Classical Adenocarcinomas in Tumor Biology and Prognosis
207. Comparative analysis of different transection techniques in minor and major hepatic resections: A prospective cohort study
208. Comparative analysis of the revenues of pylorus-preserving pancreatic head resections and laparoscopic cholecystectomies as prototypic surgical procedures in the German health-care system
209. Characterization of pericytes in adult pancreas tissue sections
210. Loss of Ppar-gamma promotes KrasG12D-driven pancreatic ductal adenocarcinoma formation by inhibiting p53 function
211. Analysis of the extracellular matrix protein periostin in early pancreatic carcinogenesis
212. Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer
213. Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels
214. Minimalinvasive Chirurgie bei Malignomen des Gastrointestinaltrakts: Pankreas - Kontra-Position
215. The actin binding protein destrin is associated with growth and perineural invasion of pancreatic cancer
216. MALDI Imaging Mass Spectrometry for In Situ Proteomic Analysis of Preneoplastic Lesions in Pancreatic Cancer
217. Energy metabolism and proliferation in pancreatic carcinogenesis
218. How fibrosis influences imaging and surgical decisions in pancreatic cancer
219. Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy
220. Differentiation of multiple types of pancreatico-biliary tumors by molecular analysis of clinical specimens
221. StellaTUM: current consensus and discussion on pancreatic stellate cell research
222. Disclosure of Erlotinib as a Multikinase Inhibitor in Pancreatic Ductal Adenocarcinoma
223. Reduced α-Dystroglycan Expression Correlates with Shortened Patient Survival in Pancreatic Cancer
224. From tissue turnover to the cell of origin for pancreatic cancer
225. Pigment Epithelium-Derived Factor Associates With Neuropathy and Fibrosis in Pancreatic Cancer
226. A Functional Role for VEGFR1 Expressed in Peripheral Sensory Neurons in Cancer Pain
227. ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer
228. Tumor metabolism to blood flow ratio in pancreatic cancer: helpful in patient stratification?
229. T-tube or no T-tube in reconstruction of the biliary tract during orthotopic liver transplantation - systematic review and meta-analysis
230. Indications for Endoscopic or Surgical Treatment of Chronic Pancreatitis
231. Diagnosing exocrine pancreatic insufficiency after surgery: when and which patients to treat
232. Confirmation of DNA Microarray-Derived Differentially Expressed Genes in Pancreatic Cancer Using Quantitative RT-PCR
233. Deorphanization of GPR109B as a Receptor for the β-Oxidation Intermediate 3-OH-octanoic Acid and Its Role in the Regulation of Lipolysis
234. Cancer-Stellate Cell Interactions Perpetuate the Hypoxia-Fibrosis Cycle in Pancreatic Ductal Adenocarcinoma
235. Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway
236. Pancreatic Islet and Stellate Cells Are the Main Sources of Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Pancreatic Cancer
237. Correction to: The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation.
238. Northern blot analysis for detection and quantification of RNA in pancreatic cancer cells and tissues
239. The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma
240. Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma
241. Systematic Review and Meta-Analysis of the Role of Defunctioning Stoma in Low Rectal Cancer Surgery
242. Neurokinin-2 Receptor Levels in Chronic Pancreatitis
243. Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells
244. CXCL14 expression and potential function in pancreatic cancer
245. Pancreatic pain
246. Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-κB in chronic pancreatitis
247. Early Undifferentiated Pancreatic Carcinoma With Osteoclastlike Giant Cells: Direct Evidence for Ductal Evolution
248. Mononuclear cells modulate the activity of pancreatic stellate cells which in turn promote fibrosis and inflammation in chronic pancreatitis
249. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion
250. Neurokinin-2 Receptor Levels Correlate With Intensity, Frequency, and Duration of Pain in Chronic Pancreatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.